Articles dans des revues avec comité de lecture (26)
  1. 13. Audouard, E., Houben, S., Masaracchia, C., Yilmaz, Z., Suain, V., Authelet, M., De Decker, R., Buée, L., Boom, A., Leroy, K., Ando, K., & Brion, J. P. (2016). High-Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo. The American journal of pathology, 186(10), 2709-2722. doi:10.1016/j.ajpath.2016.06.008
  2. 14. Ando, K., Tomimura, K., Sazdovitch, V., Suain, V., Yilmaz, Z., Authelet, M., Ndjim, M., Vergara Panos, C., Belkouch, M., Potier, M.-C., Duyckaerts, C., & Brion, J. P. (2016). Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. Neurobiology of disease, 94, 32-43. doi:10.1016/j.nbd.2016.05.017
  3. 15. Gilissen, E., Leroy, K., Yilmaz, Z., Kövari, E., Bouras, C., Boom, A., Poncelet, L., Erwin, J. J., Sherwood, C. C., Hof, P., & Brion, J. P. (2016). A neuronal aging pattern unique to humans and common chimpanzees. Brain Structure and Function (Print Edition), 221(1), 647-664. doi:10.1007/s00429-014-0931-5
  4. 16. Audouard, E., Van Hees, L., Suain, V., Yilmaz, Z., Poncelet, L., Leroy, K., & Brion, J. P. (2015). Motor Deficit in a Tauopathy Model Is Induced by Disturbances of Axonal Transport Leading to Dying-Back Degeneration and Denervation of Neuromuscular Junctions. The American journal of pathology, 185(10), 2685-2697. doi:10.1016/j.ajpath.2015.06.011
  5. 17. Ando, K., Kabova, A., Stygelbout, V., Leroy, K., Heraud, C., Frédérick, C., Suain, V., Yilmaz, Z., Authelet, M., Dedecker, R., Potier, M.-C., Duyckaerts, C., & Brion, J. P. (2014). Vaccination with Sarkosyl Insoluble PHF-Tau Decrease Neurofibrillary Tangles Formation in Aged Tau Transgenic Mouse Model: A Pilot Study. Journal of Alzheimer's disease, 40(0), S135-S145. doi:10.3233/JAD-132237
  6. 18. Heraud, C., Goufak, D., Ando, K., Leroy, K., Suain, V., Yilmaz, Z., De Decker, R., Authelet, M., Laporte, V., Octave, J. N., & Brion, J. P. (2013). Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice. Neurobiology of disease, 62C, 100-112. doi:10.1016/j.nbd.2013.09.010
  7. 19. Leroy, K., Ando, K., Laporte, V., Dedecker, R., Suain, V., Authelet, M., Heraud, C., Pierrot, N., Yilmaz, Z., Octave, J. N., & Brion, J. P. (2012). Lack of Tau Proteins Rescues Neuronal Cell Death and Decreases Amyloidogenic Processing of APP in APP/PS1 Mice. The American journal of pathology, 181(6), 1928-1940. doi:10.1016/j.ajpath.2012.08.012
  8. 20. Ando, K., Leroy, K., Heraud, C., Yilmaz, Z., Authelet, M., Suain, V., De Decker, R., & Brion, J. P. (2011). Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. The American journal of pathology, 178(2), 803-816. doi:10.1016/j.ajpath.2010.10.034
  9. 21. Ando, K., Leroy, K., Heraud, C., Kabova, A., Yilmaz, Z., Authelet, M., Suain, V., De Decker, R., & Brion, J. P. (2010). Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. Biochemical Society transactions, 38(4), 1001-1005. doi:10.1042/BST0381001
  10. 22. Leroy, K., Ando, K., Heraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.-M., Buée, L., De Decker, R., & Brion, J. P. (2010). Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. Journal of Alzheimer's disease, 19(2), 705-719. doi:10.3233/JAD-2010-1276
  11. 23. Leroy, K., De Decker, R., Suain, V., Authelet, M., Yilmaz, Z., & Brion, J. P. (2009). C9 Tau et toxicité de l’amyloïde Aß dans les modèles transgéniques APP. Revue neurologique, 165(10), 23. doi:10.1016/S0035-3787(09)72562-7
  12. 24. Killick, R., Scales, G., Leroy, K., Causevic, M., Hooper, C., Irvine, E. E., Choudhury, A. I., Drinkwater, L., Kerr, F., Al-Qassab, H., Stephenson, J., Yilmaz, Z., Giese, K. P., Brion, J. P., Withers, D. J., & Lovestone, S. (2009). Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochemical and biophysical research communications, 386(1), 257-262. doi:10.1016/j.bbrc.2009.06.032
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>